State Street’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $127M | Sell |
|
|||||
|
2024
Q1 | $149M | Buy |
|
|||||
|
2023
Q4 | $121M | Sell |
|
|||||
|
2023
Q3 | $63.3M | Buy |
|
|||||
|
2023
Q2 | $88M | Sell |
|
|||||
|
2023
Q1 | $76.5M | Sell |
|
|||||
|
2022
Q4 | $108M | Buy |
|
|||||
|
2022
Q3 | $76.8M | Buy |
|
|||||
|
2022
Q2 | $63.8M | Buy |
|
|||||
|
2022
Q1 | $75.7M | Sell |
|
|||||
|
2021
Q4 | $71.9M | Buy |
|
|||||
|
2021
Q3 | $63.8M | Buy |
|
|||||
|
2021
Q2 | $33.5M | Buy |
|
|||||
|
2021
Q1 | $12.8M | Buy |
|